Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
University of Manitoba
$105,000.00
Non-invasive determination of biomarkers in exhaled breath condensate (EBC). Effect of dietary n-3 fatty acids on selected biomarkers in both healthy individuals and patients with peripheral arterial disease (PAD) using bio-analytical separations and electronic nose.
FY 2009-10
Summary
The ability to identify biomarkers for a specific disease is critical to the early identification, treatment and ultimately even the prevention of the disease. The purpose of the present proposal is to identify novel biomarkers that improve upon those already in use. The sampling method is even more valuable if these biomarkers are detected in a non-invasive, rapid fashion. Breath analysis is one of these potentially valuable new tests. The objective of this study is to use breath samples to identify new biomarkers for cardiovascular disease and to study the effects of good dietary fatty acids (omega-3 FAs) on these biomarkers. Heart disease is believed to be reduced by diets rich in omega-3 FAs. Our research will examine the use of fish oil, milled flaxseed or flaxseed oil as dietary supplements in healthy human subjects and in patients with clinical evidence of cardiovascular disease. We will then correlate physiological data obtained from their blood samples to novel biomarkers in their breath. This will identify in these subjects biomarkers specific to n-3 fatty acid status and diseased state. Once these biomarkers have been identified, the objective will then be to identify a smell print of the entire breath sample using a technique known as electronic nose. The practical significance of this will be that manufacturing companies can then be approached to design a portable, handheld device that nurses and clinicians can use within the hospital for the quick and easy sampling of patients for diagnostic purposes.
Department
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Recipient
Location
Manitoba, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
206110
Name
Edel Andrea
Region
Manitoba
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Clinical
Prcname2
Doctoral Research Awards - A
Projecttitle
Non-invasive determination of biomarkers in exhaled breath condensate (EBC). Effect of dietary n-3 fatty acids on selected biomarkers in both healthy individuals and patients with peripheral arterial disease (PAD) using bio-analytical separations and electronic nose.
Programtype2
Studentship Programs
Orgnameinp2
University of Manitoba
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Bio-Analytical Measurements; Biomarkers In Exhaled Breath Condensate; Clinical Trials With Healthy And Unhealthy Subjects; Electronic Nose; Flaxseed/Fish Oil Intervention; Gas Chromatography-Mass Spectrometry; Metabolism; Oxidative Stress; Peripheral Arterial Disease; Ultra Performance Liquid Chromatography
Abstract
The ability to identify biomarkers for a specific disease is critical to the early identification, treatment and ultimately even the prevention of the disease. The purpose of the present proposal is to identify novel biomarkers that improve upon those already in use. The sampling method is even more valuable if these biomarkers are detected in a non-invasive, rapid fashion. Breath analysis is one of these potentially valuable new tests. The objective of this study is to use breath samples to identify new biomarkers for cardiovascular disease and to study the effects of good dietary fatty acids (omega-3 FAs) on these biomarkers. Heart disease is believed to be reduced by diets rich in omega-3 FAs. Our research will examine the use of fish oil, milled flaxseed or flaxseed oil as dietary supplements in healthy human subjects and in patients with clinical evidence of cardiovascular disease. We will then correlate physiological data obtained from their blood samples to novel biomarkers in their breath. This will identify in these subjects biomarkers specific to n-3 fatty acid status and diseased state. Once these biomarkers have been identified, the objective will then be to identify a smell print of the entire breath sample using a technique known as electronic nose. The practical significance of this will be that manufacturing companies can then be approached to design a portable, handheld device that nurses and clinicians can use within the hospital for the quick and easy sampling of patients for diagnostic purposes.
Competitiondate
200910
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Edel, Andrea
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~